Unknown PHASE4 INTERVENTIONAL 2-arm NCT02917863

Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism

Sponsor: Meyer Children's Hospital IRCCS

Interventions L-Thyroxine (oral drops, solution) L-Thyroxine (tablet, per os)

Updated 7 times since 2017 Last updated: Sep 26, 2016 Started: May 31, 2016 Primary completion: May 31, 2018 Completion: May 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypothyroidism and is currently ongoing. Meyer Children's Hospital IRCCS leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Mar 2023 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Mar 2023 [monthly]

Unknown Status PHASE4
Jun 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meyer Children's Hospital IRCCS

Data source: Meyer Children's Hospital IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Florence, Italy